Metabolic syndrome in patients receiving antipsychotic therapy

被引：0
|
作者：
Le Guillouzic, D. [1 ]
机构：
[1] Hop Paul Guiraud, Villejuif, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2011年 / 15卷 / 04期
关键词：
Metabolic syndrome; Visceral adiposity; Insulin resistance; Severe mental disorders; Antipsychotic; DRUG-NAIVE PATIENTS; ATYPICAL ANTIPSYCHOTICS; GLUCOSE-TOLERANCE; WEIGHT-GAIN; SCHIZOPHRENIA; PREVALENCE; RISPERIDONE; OLANZAPINE; DISEASE; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 106
页数：6
相关论文
共 50 条
  • [1] Metabolic syndrome in patients with schizophrenia and antipsychotic treatment
    Aguilar, Eva
    Coronas, Ramon
    Caixas, Assumpta
    MEDICINA CLINICA, 2012, 139 (12): : 542 - 546
  • [2] Metabolic syndrome in antipsychotic naive patients diagnosed with schizophrenia
    Grover, Sandeep
    Nebhinani, Naresh
    Chakrabarti, Subho
    Parakh, Preeti
    Ghormode, Deepak
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 (03) : 326 - 331
  • [3] Prognosis for the development of metabolic syndrome in patients with schizophrenia receiving antipsychotic therapy
    Dubrovskaya, V.
    Kornetova, E.
    Perchatkina, O.
    EUROPEAN PSYCHIATRY, 2020, 63 : S237 - S237
  • [4] The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone
    Lee, Nam Young
    Kim, Se Hyun
    Jung, Dong Chung
    Kim, Eun Young
    Yu, Han Young
    Sung, Ki Hye
    Kang, Ung Gu
    Ahn, Yong Min
    Kim, Yong Sik
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (05) : 1273 - 1278
  • [5] Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm
    Waterreus, Anna J.
    Laugharne, Jonathan D. E.
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (04) : 185 - 189
  • [6] Metabolic issues in schizophrenic patients receiving antipsychotic treatment
    Gupta A.
    Dadheech G.
    Yadav D.
    Sharma P.
    Gautam S.
    Indian Journal of Clinical Biochemistry, 2014, 29 (2) : 196 - 201
  • [7] Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia An Egyptian Study
    El-Gabry, Dina M. Aly
    Aziz, Karim Abdel
    Okasha, Tarek
    Azzam, Hanan
    Okasha, Ahmed
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (01) : 27 - 33
  • [8] Metabolic syndrome in schizophrenia: A comparative study of antipsychotic-free/naive and antipsychotic-treated patients from India
    Pallava, Abhishek
    Chadda, Rakesh K.
    Sood, Mamta
    Lakshmy, R.
    NORDIC JOURNAL OF PSYCHIATRY, 2012, 66 (03) : 215 - 221
  • [9] Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Said, Mas Ayu
    Sulaiman, Ahmad Hatim
    Habil, Mohd Hussain
    Das, Srijit
    Abu Bakar, Abdul Kadir
    Yusoff, Rosliwati Md
    Loo, Tsui Huei
    Abu Bakar, Shamshunnisah
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (12) : 801 - 807
  • [10] Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
    Kornetova, Elena G.
    Kornetov, Alexander N.
    Mednova, Irina A.
    Dubrovskaya, Viktoria V.
    Boiko, Anastasia S.
    Bokhan, Nikolay A.
    Loonen, Anton J. M.
    Ivanova, Svetlana A.
    FRONTIERS IN PSYCHIATRY, 2019, 10
12345